US
CA
NZ
UK
AU
IND
Company Profile:
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of various vaccines to prevent serious infectious diseases. The company's recombinant technology platform harnesses the power and speed of genetic engineering to produce immunogenic nanoparticles designed to address urgent global health needs. The company is also evaluating its COVID-19-Influenza Combination vaccine candidate, its quadrivalent influenza investigational vaccine candidate, and an Omicron strain-based vaccine, as well as a bivalent format Omicron-based/original strain-based vaccine.
Summary Table
Stock Price Chart and Technical Summary
Markets are trading in a highly volatile zone currently due to certain macroeconomic and geopolitical tensions prevailing. Therefore, it is prudent to follow a cautious approach while investing.
Note 1: Past performance is not a reliable indicator of future performance.
Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is February 16, 2022. The reference data in this report has been partly sourced from REFINITIV.
Kalkine Equities LLC provides general information about companies and their securities. The information contained in the reports, including any recommendations regarding the value of or transactions in any securities, does not take into account any of your investment objectives, financial situation or needs. Kalkine Equities LLC is not registered as an investment adviser in the U.S. with either the federal or state government. Before you make a decision about whether to invest in any securities, you should take into account your own objectives, financial situation and needs and seek independent financial advice. All information in our reports represents our views as at the date of publication and may change without notice.
Kalkine Media LLC, an affiliate of Kalkine Equities LLC, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.
Please wait processing your request...